Heart procedure put to the test: placebo surgery reveals true benefits for chest pain

NCT ID NCT05142215

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a procedure to open a fully blocked heart artery (CTO PCI) actually reduces chest pain in people with stable angina. Fifty patients received either the real procedure or a placebo procedure, while all continued their usual heart medications. The goal was to see if the procedure offers any extra symptom relief beyond what patients already get from drugs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Percutaneous coronary intervention (coronary angioplasty with drug-eluting stents)
What this could lead to
If it works, this could show that opening a fully blocked artery with a stent reduces chest pain better than a placebo procedure in people already on heart medications.
What could go wrong
This is a small pilot study with only 50 participants, so results may not apply to everyone. The procedure carries risks like bleeding, heart attack, or stroke, and the placebo effect can be strong for symptom relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC TOTAL OCCLUSION OF CORONARY ARTERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Angina Pectoris Angina, Stable

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Essex Cardiothoracic Centre

    Basildon, Essex, SS16 5NL, United Kingdom

  • Royal Bournemouth Hospital

    Bournemouth, BH7 7DW, United Kingdom

  • St. George's University Hospitals NHS Foundation Trust

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.